Karyopharm Therapeutics
	Developer of drugs for the treatment of cancer, inflammation and diseases related to cell proliferation. The company focuses on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.
	['', 'cancer treatment', ' ', 'inflammation drug', ' ', 'cell proliferation', '']
Quanticel Pharmaceuticals
	Developer of medicines for the treatment of cancer and other life-threatening diseases. The company provides a platform for single-cell genomic analysis of human cancer.
	['', 'therapeutic treatment', ' ', 'medicine development', ' ', 'disease treatment', '']
Molecular Engines Laboratories
	Developer of a new generation of drugs against cancer. The company\'s research is focused on the analysis and understanding of the molecular mechanism which makes it possible for a cancer cell to quit its malignant state and to revert to a suppressed-malignant phenotype.
	['', 'cancer drug', ' ', 'cancer cell analysis', ' ', 'cancer research', '']
ACT Biotech
	Developer of cancer drugs. The company is focused on the development and commercialization of targeted oral and cancer drugs.
	['', 'oral cancer', ' ', 'cancer treatment', '']
Matrix Therapeutics
	Developer of drugs for the treatment of cancer and inflammatory diseases. The company\'s product TO2 is a natural non-opioid compound combining anesthetic and analgesic activity, but without causing respiratory depression or lowering blood pressure. The company is a spin out from The University of Manchester.
	['', 'inflammatory diseases', ' ', 'cancer drugs', ' ', 'non-opioid compound', ' ', 'drug research', '']
Velocity Medical Solutions
	Developer of imaging software to improve cancer treatment. The company offers a software which could improve the planning of radiation therapy for patients and develop new cancer therapies. It builds oncology PACS applicable to the research, clinical, and drug discovery markets.
	['', 'cancer treatment', ' ', 'imaging system', ' ', 'radiation therapy', ' ', 'cancer therapy', '']
Encore Pharmaceuticals
	Developer of drugs for clinical applications in the pharmaceutical and nutritional fields. The company\'s products enables treatment and prevention of cancer, neurologic and cardiovascular diseases.
	['', 'drug development', ' ', 'proprietary products', ' ', 'bio-pharmaceutical research', ' ', 'clinical applications', '']
JSK Therapeutics
	Developer of novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells. The company\'s business is based on two types of drugs, the first class of drug, has been tested in animal systems and the second class of drugs is not as developed as a cancer drug but is more versatile with wider range of cancers.
	['', 'cancer therapy', '']
Mycologix
	Provider of a biological treatment process for biofuels. The company uses a combination of microbial treatment and engineering to degrade woody material on an industrial scale, to be fermented into fuels such as ethanol.
	['', 'wood decay mechanisms', ' biomass bioenergy biofuel']
Arbutus Biopharma
	Provider of ribonucleic acid (RNA) interference therapeutics and lipid nanoparticle delivery technology to pharmaceutical partners. The company focuses on the development of internal product candidates that include apolipoprotein B (ApoB) SNALP for the treatment of high cholesterol and polo-like kinase 1 (PLK1) SNALP for the treatment of cancer.
	['', 'RNA interference therapeutics', ' ', 'lipid drug delivery', ' ', 'high cholesterol treatment', ' ', 'therapeutic device', '']
Apalexo Biotechnologie
	Operator of a biopharmaceutical company focused on cancer treatment. The company is focused on development of a treatment to eradicate residual tumor cells following conventional cancer therapies.
	['immunotherapeutics cellular']
Jennerex Biotherapeutics
	Developer of oncolytic products for cancer. The company\'s products include JX-594, an engineered oncolytic virus that selectively targets and destroys cancer cells, JX-929 that targets the epidermal growth factor receptor and ras signal transduction pathways and JX-963, which is engineered from a strain of vaccinia virus.
	['', 'cancer treatment', ' ', 'oncolytic product development', ' ', 'vaccinia virus', ' ', 'epidermal growth', '']
IOmet Pharma
	Developer of drugs in the preclinical area of the drug discovery process. The company focuses on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism.
	['', 'drug discovery', ' ', 'nervous system disorder', ' ', 'oncology therapeutic', '']
Cancer Genetics
	Developer of personalized medicines for cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual. The company provides cancer patient management to diagnose, monitor and inform treatment of cancer.
	['', 'cancer diagnostic', ' ', 'cancer treatment', ' ', 'cancer patient management', '']
KuDOS Pharmaceuticals
	Developer of oncology drugs. The company develops drugs for combination with chemo- and radiotherapy, based on expertise in DNA repair mechanisms for treatment of cancer.
	['', 'cancer treatment', ' ', 'drug discovery', ' ', 'drug delivery', '']
Conforma Therapeutics
	Developer of drugs for the treatment of cancer. The company develops drugs that induce tumor cells to degrade the proteins that promote cancer growth. It offers the HSP90 product, CNF1010 which is used for the treatment of cancer.
	['', 'cancer treatment', ' ', 'tumor cell', ' ', 'cancer growth', '']
Pathway Therapeutics
	Developer of therapeutics against human diseases. The company offers PI3 kinase, an enzyme identified as active in cancer tumor development.
	['', 'drug development', ' ', 'cancer treatment', ' ', 'lifesciences and oncology', '']
Nereus Pharmaceuticals
	Developer of therapeutic drugs for the treatment of cancer. The company is engaged in discovery and development of therapeutic medicines and drugs which are used in the treatment of tumors, cancer, colon, prostate and other inflammatory diseases.
	['', 'marine microbiology technology', '  therapeutic ', 'development of therapeutic', ' ', 'treatment of oncology', '']
Kite Pharma
	Developer of active immunotherapies for cancer. The company has a portfolio of proprietary product candidates designed to stimulate the patient\'s own immune system to fight tumor cells.
	['', 'cancer therapy', ' ', 'cancer immunotherapy', ' ', 'cancer treatment', ' ', 'tumor treatment', '']
Algeta
	Developer of novel targeted therapies for patients with cancer, based on its alpha-pharmaceutical platform. The company is focused to extend and improve cancer patient\'s lives by developing targeted therapies to fulfill unmet medical needs. It\'s lead product Alpharadin is used for treatment for cancer patients with bone metastases. They are also developing thorium targeted conjugates which are based on conjugating the alpha-emitter thorium-227 to tumor-targeting molecules.
	['', 'cancer drug', ' ', 'targeted therapy', ' ', 'bone metastase', '']
ZGene
	Provider of gene therapeutics for the treatment of cancer diseases. The company develops treatments for several cancer forms with an enzyme based gene suicide system that increase the activation of anti-cancer drugs in tumour cells with faster cell death.
	['', 'cancer treatment', ' ', 'gene suicide', ' ', 'anti-cancer drugs', '']
GITR
	Developer of oncological therapies. The company is developing TRX518, a humanized monoclonal antibody that is reactive with the glucocorticoid-induced tumor necrosis factor receptor (GITR), for the treatment of cancer.
	['', 'chemotherapeutic treatment', ' ', 'tumor markers', ' ', 'T cell', '']
